# Strategic Reframing Update Summary
## MICCAI 2026 Documents

**Date**: 2026-02-20  
**Purpose**: Positioning and consistency correction (NOT a full rewrite or results change)

---

## A) Revised Contribution Statement

The Contribution Statement has been completely revised with the following changes:

### Key Changes:
1. **Reordered Contributions**: 
   - **Primary**: Calibrated Ensemble Meta-Learning (moved from #2 to #1)
   - **Secondary**: Clinical Threshold Control and Probability Reliability (new #2)
   - **Tertiary**: Quantitative Interpretability Analysis (moved from #3, ROI-MIL now supporting evidence)

2. **MIL Configuration Clarification**:
   - Explicitly states "DualStreamMIL-3D with **entropy-based slice selection**" as the final configuration
   - ROI-guided selection mentioned only as "complementary validation experiment" providing "supporting evidence"

3. **Clinical Framing Strengthened**:
   - Emphasizes "calibrated, robust multimodal ensemble framework"
   - Highlights "probability reliability", "operating point selection", "FN-sensitive deployment"
   - Positions framework as addressing "critical clinical deployment limitations"

4. **Tone Shift**:
   - From "MIL architecture paper" to "robust clinical AI system"
   - Emphasizes calibration-aware deployment, decision controllability, balanced FN/FP control

---

## B) List of Modified Sections

### 1. Contribution Statement (`MICCAI_2026_CONTRIBUTION_STATEMENT.md`)
- **Section**: "Novel Contributions" (entire section rewritten)
- **Changes**: 
  - Reordered contributions (calibrated ensemble first)
  - Clarified entropy-based MIL is final configuration
  - Repositioned ROI-MIL as validation experiment
  - Strengthened clinical framing throughout

### 2. Interpretability Section (`MICCAI_2026_INTERPRETABILITY_AND_QUALITATIVE_ANALYSIS.md`)
- **Section 1.2**: "Multiple Instance Learning Attention Visualization"
  - Added note that entropy-based selection is final deployed configuration
  - Added explicit statement that SwinUNETR interpretability was not included due to complexity

- **Section 1.3**: "Hierarchical Interpretability Analysis"
  - Clarified ROI-based MIL is "validation experiment for anatomical alignment analysis"

- **Section 3.1**: "Entropy-Based MIL (Final Deployed Configuration)"
  - Renamed from "Entropy-Based vs. ROI-Based Slice Selection"
  - Positioned entropy-based as final configuration
  - Moved ROI comparison to separate section 3.2

- **Section 3.2**: "ROI-Based MIL: Anatomical Alignment Validation Experiment"
  - New section title explicitly marking ROI-MIL as validation experiment
  - Added statement: "evaluated **solely for interpretability analysis** and is **not part of the final deployed ensemble**"
  - Rephrased findings as "supporting evidence" and "validation of MIL mechanism"

- **Section 3.3**: "Failure Case Analysis"
  - Updated to clarify ROI variant is validation experiment
  - Added ensemble correction discussion

- **Section 4.1**: "Tumor Localization"
  - Clarified entropy-based is final configuration
  - Repositioned ROI variant as validation experiment providing supporting evidence
  - Added note about SwinUNETR interpretability

- **Section 4.2**: "Clinical Interpretability"
  - Updated to emphasize entropy-based as final configuration
  - Repositioned ROI-based findings as supporting evidence

- **Section 4.3**: "Failure Mode Insights"
  - Updated to clarify ROI-based is validation experiment

- **Section 5.1**: "Current Limitations"
  - Updated segmentation dependency note to clarify entropy-based doesn't require masks
  - Clarified SwinUNETR interpretability limitation

- **Section 6**: "Summary"
  - Repositioned ROI-MIL as validation experiment
  - Emphasized entropy-based as final configuration

### 3. Results Section (`MICCAI_2026_PAPER_READY_RESULTS.md`)
- **Section**: "Ensemble Performance"
  - Strengthened clinical framing: "clinically critical benefits", "probability calibration", "FN/FP control", "robustness"

- **Section**: "Probability Calibration"
  - Added emphasis on "reliability of ensemble predictions for clinical deployment"
  - Strengthened language: "significantly improved probability reliability", "clinically critical"
  - Emphasized "flexible operating point control"

- **Section**: "False Negative Reduction"
  - Added emphasis on "FN-sensitive deployment capability"
  - Highlighted high-sensitivity threshold performance

- **Section**: "Error Correction"
  - Renamed to "Error Correction and Complementary Model Behavior"
  - Added discussion of complementary signals and deployment risk reduction

- **Section**: "Summary"
  - Completely rewritten to emphasize:
    - "Calibrated, robust multimodal ensemble framework"
    - "Entropy-based slice selection" (final configuration)
    - "Calibration-aware design, operating point controllability, complementary model behavior"

### 4. Consolidated Experimental Design (`MICCAI_2026_CONSOLIDATED_EXPERIMENTAL_DESIGN.md`)
- **Section 2.1**: "DualStreamMIL-3D"
  - Added "(FINAL CONFIGURATION)" to title
  - Explicitly stated "entropy-based selection - FINAL"
  - Clarified slice selection method

- **Section 2.3**: "ROI-Based MIL"
  - Renamed to "ROI-Based MIL (INTERPRETABILITY VALIDATION ONLY)"
  - Added explicit statement: "Evaluated **solely for interpretability analysis and anatomical alignment validation**. **NOT part of the final deployed ensemble**."

- **Section 4.1**: "System Architecture"
  - Clarified "entropy-based slice selection - FINAL CONFIGURATION"

- **Section 11**: "Final Configuration Summary"
  - Updated system description to "Calibrated, Robust Multimodal Ensemble"
  - Added "entropy-based slice selection" clarification
  - Added "Clinical Features" bullet point
  - Added explicit note about ROI-Based MIL status

---

## C) Brief Summary of Framing Adjustments

### 1. Final MIL Configuration Clarification ✅
- **Before**: Ambiguous about which MIL variant is final; ROI-MIL sometimes presented as main innovation
- **After**: Explicitly states entropy-based MIL is final deployed configuration; ROI-MIL is validation experiment only
- **Impact**: Eliminates confusion about system architecture; clarifies that ROI-MIL is not part of deployed system

### 2. Contribution Statement Reordering ✅
- **Before**: ROI-guided MIL presented as primary contribution (#1); calibrated ensemble as secondary (#2)
- **After**: Calibrated ensemble as primary (#1); clinical threshold control as secondary (#2); interpretability as tertiary (#3) with ROI-MIL as supporting evidence
- **Impact**: Positions work as robust clinical AI system, not primarily a MIL architecture paper

### 3. Clinical Framing Strengthening ✅
- **Before**: Emphasis on AUC comparison; calibration mentioned but not emphasized
- **After**: Strong emphasis on:
  - Probability reliability (Brier, ECE improvements highlighted)
  - Operating point control (balanced vs. high-sensitivity thresholds)
  - FN-sensitive deployment capability
  - Robustness across folds
  - Complementary model behavior
- **Impact**: Shifts focus from pure performance metrics to clinical deployment readiness

### 4. Interpretability Section Consistency ✅
- **Before**: ROI-based MIL findings presented as central method; SwinUNETR interpretability not explicitly addressed
- **After**: 
  - ROI-based MIL clearly marked as "validation experiment" and "not part of final deployed ensemble"
  - SwinUNETR interpretability explicitly stated as not included due to complexity
  - Entropy-based MIL consistently marked as final configuration
- **Impact**: Eliminates confusion about which MIL variant is used; clarifies interpretability scope

### 5. Consistency Check ✅
- **Verified**: All documents now consistently state:
  - Entropy-based MIL is final configuration
  - ROI-based MIL is interpretability-focused validation experiment
  - Ensemble is calibration-aware and clinically robust
  - No contradictions between documents
- **Impact**: Ensures coherent narrative across all submission documents

---

## Verification Checklist

- ✅ No document contradicts final configuration
- ✅ Entropy-based MIL consistently marked as final
- ✅ ROI-based MIL consistently marked as interpretability-focused
- ✅ Ensemble positioned as calibration-aware and clinically robust
- ✅ No numerical values or results altered
- ✅ No fabricated results
- ✅ Clinical framing strengthened throughout
- ✅ Contribution hierarchy corrected (calibrated ensemble → threshold control → interpretability)

---

## Documents Modified

1. `reports/MICCAI_2026_CONTRIBUTION_STATEMENT.md` - Complete revision
2. `reports/MICCAI_2026_INTERPRETABILITY_AND_QUALITATIVE_ANALYSIS.md` - Multiple sections updated
3. `reports/MICCAI_2026_PAPER_READY_RESULTS.md` - Clinical framing strengthened
4. `reports/MICCAI_2026_CONSOLIDATED_EXPERIMENTAL_DESIGN.md` - Final configuration clarified

---

**Status**: ✅ All strategic reframing updates completed successfully

